Wall Street brokerages expect Safeguard Scientifics, Inc (NYSE:SFE) to report earnings of ($1.05) per share for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for Safeguard Scientifics’ earnings. Safeguard Scientifics posted earnings of ($1.07) per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 1.9%. The firm is scheduled to announce its next quarterly earnings results before the market opens on Thursday, March 1st.
On average, analysts expect that Safeguard Scientifics will report full-year earnings of ($4.47) per share for the current financial year. For the next financial year, analysts forecast that the company will report earnings of ($4.00) per share. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for Safeguard Scientifics.
A number of equities research analysts recently weighed in on SFE shares. Zacks Investment Research upgraded Safeguard Scientifics from a “hold” rating to a “buy” rating and set a $16.00 price objective for the company in a research note on Thursday, November 2nd. Keefe, Bruyette & Woods restated a “mkt perform” rating and set a $13.25 price objective on shares of Safeguard Scientifics in a research note on Wednesday, December 6th. Finally, ValuEngine cut Safeguard Scientifics from a “hold” rating to a “sell” rating in a research note on Tuesday, November 14th.
Shares of Safeguard Scientifics (NYSE SFE) traded down $0.15 during midday trading on Tuesday, hitting $12.35. The company had a trading volume of 9,410 shares, compared to its average volume of 142,838. The company has a quick ratio of 1.03, a current ratio of 1.03 and a debt-to-equity ratio of 0.45. The stock has a market cap of $257.20, a PE ratio of -2.75 and a beta of 1.36. Safeguard Scientifics has a 1 year low of $10.65 and a 1 year high of $14.40.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.